Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
ReliaQuest, the leader in agentic AI security operations, today released its 2026 Annual Threat Report, which shows threat actors utilizing AI and automation tools can now achieve lateral movement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results